相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pimavanserin reverses multiple measures of anxiety in a rodent model of post-traumatic stress disorder
David H. Malin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases
Mingyue Wang et al.
BRAIN RESEARCH BULLETIN (2021)
Pimavanserin Promotes Trophic Factor Release and Protects Cultured Primary Dopaminergic Neurons Exposed to MPP plus in a GDNF-Dependent Manner
Elodie Gras Lavigne et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Lack of antidepressant effects of burst-suppressing isoflurane anesthesia in adult male Wistar outbred rats subjected to chronic mild stress
Wiebke Theilmann et al.
PLOS ONE (2020)
Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice
Sha-Sha Zhang et al.
PSYCHOPHARMACOLOGY (2019)
Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy
Anne Kaer Gejl et al.
SCIENTIFIC REPORTS (2019)
proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing
Catherine Fleitas et al.
MOLECULAR BRAIN (2018)
BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
Przemyslaw Kowianski et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Stability of BDNF in Human Samples Stored Up to 6 Months and Correlations of Serum and EDTA-Plasma Concentrations
Maryna Polyakova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Isoflurane produces antidepressant effects and induces TrkB signaling in rodents
Hanna Antila et al.
SCIENTIFIC REPORTS (2017)
The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson's disease subjects
Francesco Angelucci et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Low BDNF is associated with cognitive impairments in patients with Parkinson's disease
Yu Wang et al.
PARKINSONISM & RELATED DISORDERS (2016)
Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?
Montserrat Serra-Millas
WORLD JOURNAL OF PSYCHIATRY (2016)
Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease
Michaela E. Johnson et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2015)
Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system
Mimi Tang et al.
PHYSIOLOGY & BEHAVIOR (2015)
Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease
Nancy G. Hernandez-Chan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Jeffrey Cummings et al.
LANCET (2014)
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson's Psychosis
Uli Hacksell et al.
NEUROCHEMICAL RESEARCH (2014)
Emulsified isoflurane anesthesia decreases brain-derived neurotrophic factor expression and induces cognitive dysfunction in adult rats
Fan Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Upregulation of blood proBDNF and its receptors in major depression
Li Zhou et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2013)
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease
Krista McFarland et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Association of plasma brain-derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris
Hong Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Blood BDNF concentrations reflect brain-tissue BDNF levels across species
Anders B. Klein et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients
E. N. Rizos et al.
SCHIZOPHRENIA RESEARCH (2011)
Management of Hallucinations and Psychosis in Parkinson's Disease
Marty L. Eng et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2010)
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Elin B. Forsaa et al.
ARCHIVES OF NEUROLOGY (2010)
Neurotransmission in Parkinson's disease: beyond dopamine
P. Barone
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology
Anilkumar Pillai et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
Herbert Y. Meltzer et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Parkinson's disease psychosis 2010 A review article
Joseph H. Friedman
PARKINSONISM & RELATED DISORDERS (2010)
Plasma BDNF and tPA are associated with late-onset geriatric depression
Yanyan Shi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
Paul Shotbolt
Neuropsychiatric Disease and Treatment (2010)
Control of extracellular cleavage of ProBDNF by high frequency neuronal activity
Guhan Nagappan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants
Marianne H. Larsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder
Flavio Kapczinski et al.
Expert Review of Neurotherapeutics (2008)
Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia
Anilkumar Pillai
NEUROSIGNALS (2008)
Proteolysis of proBDNF Is a Key Regulator in the Formation of Memory
Philip Barnes et al.
PLOS ONE (2008)
Brain derived neurotropic factor in first-episode psychosis
Peter F. Buckley et al.
SCHIZOPHRENIA RESEARCH (2007)
Effect of quetiapine a double-blind in psychotic Parkinson's disease patients: Labeled study of 3 months' duration
Jose M. Rabey et al.
MOVEMENT DISORDERS (2007)
Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions
Raffaella Molteni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist
KE Vanover et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus
A Pillai et al.
SCHIZOPHRENIA RESEARCH (2006)
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
WG Ondo et al.
MOVEMENT DISORDERS (2005)
ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin
HK Teng et al.
JOURNAL OF NEUROSCIENCE (2005)
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
CR Bramham et al.
PROGRESS IN NEUROBIOLOGY (2005)
The impact of age, weight and gender on BDNF levels in human platelets and plasma
M Lommatzsch et al.
NEUROBIOLOGY OF AGING (2005)
Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone
M Banasr et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Psychiatric comorbidities in patients with Parkinson disease and psychosis
L Marsh et al.
NEUROLOGY (2004)
Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity
PT Pang et al.
SCIENCE (2004)
Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets
F Karege et al.
NEUROSCIENCE LETTERS (2002)
The role of brain-derived neurotrophic factor receptors in the mature hippocampus: Modulation of long-term potentiation through a presynaptic mechanism involving TrkB
BJ Xu et al.
JOURNAL OF NEUROSCIENCE (2000)
Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor
T Nakahashi et al.
FEBS LETTERS (2000)
分享论文
